Organic and Medicinal Chemistry Division, CSIR-Indian Institute of Chemical Biology, 4, Raja SC Mullick Road, Kolkata 700 032, India.
Structural Biology and Bioinformatics Division, CSIR-Indian Institute of Chemical Biology, 4, Raja SC Mullick Road, Kolkata 700 032, India.
Biochim Biophys Acta Gen Subj. 2020 May;1864(5):129557. doi: 10.1016/j.bbagen.2020.129557. Epub 2020 Feb 8.
Polyamines can induce protein aggregation that can be related to the physiology of the cellular function. Polyamines have been implicated in protein aggregation which may lead to neuropathic and non neuropathic amyloidosis.
Change in the level of polyamine concentration has been associated with ageing and neurodegeneration such as Parkinson's disease, Alzheimer's disease. Lysozyme aggregation in the presence of polyamines leads to non neuropathic amyloidosis. Polyamine analogues can suppress or inhibit protein aggregation suggesting their efficacy against amyloidogenic protein aggregates.
In this study we report the comparative interactions of lysozyme with the polyamine analogue, 1-naphthyl acetyl spermine in comparison with the biogenic polyamines through spectroscopy, calorimetry, imaging and docking techniques. The findings revealed that the affinity of binding varied as spermidine > 1-naphthyl acetyl spermine > spermine. The biogenic polyamines accelerated the rate of fibrillation significantly, whereas the analogue inhibited the rate of fibrillation to a considerable extent. The polyamines bind near the catalytic diad residues viz. Glu35 and Asp52, and in close proximity of Trp62 residue. However, the analogue showed dual nature of interaction where its alkyl amine region bind in same way as the biogenic polyamines bind to the catalytic site, while the naphthyl group makes hydrophobic contacts with Trp62 and Trp63, thereby suggesting its direct influence on fibrillation.
This study, thus, potentiates, the development of a polyamine analogue that can perform as an effective inhibitor targeted towards aggregation of amyloidogenic proteins.
多胺可以诱导蛋白质聚集,这可能与细胞功能的生理学有关。多胺已被牵连到蛋白质聚集,这可能导致神经病变和非神经病变的淀粉样变性。
多胺浓度的变化与衰老和神经退行性疾病如帕金森病、阿尔茨海默病有关。溶菌酶在多胺存在下的聚集导致非神经病变的淀粉样变性。多胺类似物可以抑制或抑制蛋白质聚集,表明它们对淀粉样蛋白聚集物的疗效。
在这项研究中,我们报告了比较溶菌酶与多胺类似物 1-萘乙酰基 spermine 的相互作用,与生物多胺通过光谱学、量热法、成像和对接技术。研究结果表明,结合的亲和力不同,为 spermidine > 1-萘乙酰基 spermine > spermine。生物多胺显著加速了纤维形成的速度,而类似物则在很大程度上抑制了纤维形成的速度。多胺结合在靠近催化二联体残基附近,即 Glu35 和 Asp52,并且在 Trp62 残基附近。然而,类似物表现出双重相互作用的性质,其烷基胺区域以与生物多胺结合到催化位点相同的方式结合,而萘基与 Trp62 和 Trp63 形成疏水性接触,从而表明其对纤维形成的直接影响。
因此,这项研究促进了多胺类似物的发展,该类似物可以作为针对淀粉样蛋白聚集的有效抑制剂。